Science Explorer Interactive view Map
Research facility · Villejuif · ??

Prédicteurs moléculaires et nouvelles cibles en oncologie

gustaveroussy.fr/fr/umr-981ROR OpenAlex
Research works
28
▲ 28300% vs 2013–17
Citations
244
8.8 per fractional work
Top-10% rate
15.2%
record average 16.5%
Open access
28%
world 28%

Not ranked overall: Prédicteurs moléculaires et nouvelles cibles en oncologie is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.62× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 4.34× its world share, 0 worksImmunology and Micro…Neuroscience: 0.08× its world share, 0 worksNeuroscienceChemistry: 0.08× its world share, 0 worksChemistryComputer Science: 0.56× its world share, 0 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringMathematics: 3.04× its world share, 0 worksMathematicsMedicine: 2.21× its world share, 4 worksMedicineEconomics, Econometrics and Finance: 1.55× its world share, 0 worksEconomics, Econometr…Psychology: 0.09× its world share, 0 worksPsychologySocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.6×. Every wedge is a field page.

Which keywords describe research at Prédicteurs moléculaires et nouvelles cibles en oncologie?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Melanoma, Deep Learning, Genetic Alterations, Tumor Staging, Cancer Therapy, Dermoscopy and Skin Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Immunotherapy5▲ 26×11 topics
  2. Melanoma4▲ 319×2 topics
  3. Deep Learning4▲ 6.2×6 topics
  4. Epidemiology3▲ 2.8×5 topics
  5. Genetic Alterations3▲ 155×2 topics
  6. Tumor Staging3▲ 120×2 topics
  7. Cancer Therapy3▲ 17×5 topics
  8. Dermoscopy3▲ 316×1 topic
  9. Skin Cancer3▲ 171×1 topic
  10. Targeted Therapy2▲ 42×4 topics
  11. Chemotherapy2▲ 9.7×17 topics
  12. Glycosylation2▲ 30×2 topics
  13. BRAF gene2▲ 325×1 topic
  14. Immune Response2▲ 9.6×2 topics
  15. MAP Kinase2▲ 325×1 topic
  16. Cancer2▲ 3.9×15 topics
  17. Quality of Life2▲ 4.2×4 topics
  18. BET Bromodomains1▲ 242×1 topic
  19. Biomarkers1▲ 8.3×4 topics
  20. Innate Immunity1▲ 14×2 topics
  21. PROTACs1▲ 242×1 topic
  22. Transcriptional Regulation1▲ 20×2 topics
  23. Clinical Trials1▲ 7.8×6 topics
  24. Fc Receptors1▲ 48×1 topic
  25. Therapeutic Antibodies1▲ 37×1 topic
  26. Antigen Presentation1▲ 41×2 topics
  27. Apoptosis1▲ 10.0×3 topics
  28. Cancer Genomics1▲ 70×1 topic
  29. Genomic Instability1▲ 33×2 topics
  30. Immunity1▲ 12×4 topics
  31. Mutational Signatures1▲ 70×1 topic
  32. Cancer Immunotherapy1▲ 26×1 topic
  33. Cantharidin1▲ 968×1 topic
  34. Dendritic Cells1▲ 32×1 topic
  35. Protein Phosphatase Inhibitors1▲ 968×1 topic
  36. Tumor Microenvironment1▲ 10×5 topics

Which research topics does Prédicteurs moléculaires et nouvelles cibles en oncologie publish most on?

By volume in 2022–2025: Melanoma and MAPK Pathways, Cutaneous Melanoma Detection and Management, Cancer Cells and Metastasis and Protein Degradation and Inhibitors.

Melanoma and MAPK Pathways: 1 fractional worksCutaneous Melanoma Detection and Management: 1 fractional worksCancer Cells and Metasta…1Cancer Cells and Metastasis: 1 fractional worksProtein Degradation and …1Protein Degradation and Inhibitors: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksStatistical Methods in C…0Statistical Methods in Clinical Trials: 0 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksMicrotubule and mitosis dynamics: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional works
Molecular BiologyOncologyStatistics and ProbabilityImmunology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Melanoma and MAPK Pathways Molecular Biology 1 works
  2. 2 Cutaneous Melanoma Detection and Management Oncology 1 works
  3. 3 Cancer Cells and Metastasis Oncology 1 works
  4. 4 Protein Degradation and Inhibitors Molecular Biology 1 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Statistical Methods in Clinical Trials Statistics and Probability 0 works
  7. 7 Immune Cell Function and Interaction Immunology 0 works
  8. 8 Microtubule and mitosis dynamics Cell Biology 0 works
  9. 9 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  10. 10 Bladder and Urothelial Cancer Treatments Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.5%not open72.5%

World: 28% of research is openly available.

with international co-authors10.7%domestic only89.3%

World: 19% is written across borders.

How has Prédicteurs moléculaires et nouvelles cibles en oncologie's research output changed?

Output in 2018–2022 was 28300% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Villejuif

All research institutions in Villejuif

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.